NKTR
$39.22+7.04%
Nektar TherapeuticsStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.004% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
NKTR — Nektar Therapeutics price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeS
200.0400.0600.0800.01000.01200.01400.01600.0050.0M$39.22—20162019202120242026
2026-10-20
Price$39.22
MA20$63.97
MA50$60.37
Vol3.3M
Key stats#
Price data
- Price
- $39.22
- YTD price return
- -7.24%
- YTD total return
- -7.24%
- Next earnings
- Nov 5, 2026
- Market cap
- 1.3B
- Enterprise value
- 1.4B
- Shares outstanding
- 34.1M
- 52W low
- $33.40
- 52W high
- $109.00
- From 52W high
- -64.02%
- From 52W low
- +17.43%
- 52W range
- 8%
Volume
- Rel volume
- 0.58×
- 30D volume
- 1.7M
- 30D $ vol
- 88.8M
Fundamentals
- Sales (ttm)
- 54.6M
- Sales/share
- $1.60
- EPS (ttm)
- -$6.47
- FCF (ttm)
- -234M
- FCF/share
- -$6.85
- Book value/share
- $26.45
- Net margin
- -287.84%
- ROE
- -17.40%
- ROA
- -14.35%
- Current ratio
- 10.42
Growth (CAGR, ttm) · 10Y
- Sales
- -27.17%-14.63%-12.34%-11.77%
- Shares
- +79.60%n/an/an/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- -59.45%n/an/an/a
- Price
- -37.76%+71.30%-30.60%-15.04%
- Total return
- -37.76%+71.30%-30.60%-15.04%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -6.1×
- Fwd P/E
- -3.6×
- P/S (ttm)
- 24.5×
- P/B (mrq)
- 1.5×
- EV/Sales (ttm)
- 25.4×
- FCF yield (ttm)
- -17.48%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Performance · price return · as of 2026-10-20#
1D
+7.04%
5D
+3.43%
1M
-41.55%
3M
-39.51%
YTD
-7.24%
1Y
-37.74%
5Y
-83.90%
Financial statements
Open full NKTR financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
